Per Oskarsson

1.2k total citations · 1 hit paper
15 papers, 915 citations indexed

About

Per Oskarsson is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Per Oskarsson has authored 15 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 8 papers in Surgery. Recurrent topics in Per Oskarsson's work include Diabetes Management and Research (10 papers), Diabetes and associated disorders (9 papers) and Pancreatic function and diabetes (8 papers). Per Oskarsson is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes and associated disorders (9 papers) and Pancreatic function and diabetes (8 papers). Per Oskarsson collaborates with scholars based in Sweden, Netherlands and Austria. Per Oskarsson's co-authors include Jan Bolinder, Nataša Bratina, Moshe Phillip, Tadej Battelino, Revital Nimri, P. E. Lins, Per‐Eric Lins, Jan‐Gustaf Ljunggren, Ulf Adamson and Jens Kröger and has published in prestigious journals such as Diabetes Care, Diabetes and Diabetologia.

In The Last Decade

Per Oskarsson

14 papers receiving 859 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

2011 350 citations Tadej Battelino, Moshe Phillip et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Per Oskarsson Sweden	10	704	476	435	120	82	15	915
A. M. Rambotti Italy	9	682 1.0×	353 0.7×	262 0.6×	118 1.0×	107 1.3×	13	853
Troels Mygind Jensen Denmark	11	327 0.5×	146 0.3×	45 0.1×	210 1.8×	148 1.8×	22	647
Deborah Hinnen United States	12	809 1.1×	216 0.5×	130 0.3×	76 0.6×	172 2.1×	25	961
Lisa M. Younk United States	13	393 0.6×	166 0.3×	110 0.3×	91 0.8×	114 1.4×	20	550
Patrick J. Boyle United States	12	288 0.4×	117 0.2×	101 0.2×	81 0.7×	69 0.8×	20	465
Alexis M. McKee United States	9	167 0.2×	161 0.3×	56 0.1×	119 1.0×	94 1.1×	25	426
W Berger Switzerland	14	240 0.3×	81 0.2×	120 0.3×	99 0.8×	45 0.5×	33	467
J. Ybarra Spain	12	216 0.3×	139 0.3×	39 0.1×	206 1.7×	88 1.1×	25	582
Simon Bruce United States	10	421 0.6×	169 0.4×	30 0.1×	68 0.6×	232 2.8×	14	723
Lixin Guo China	12	208 0.3×	79 0.2×	50 0.1×	103 0.9×	87 1.1×	42	418

Countries citing papers authored by Per Oskarsson

Since Specialization

Citations

This map shows the geographic impact of Per Oskarsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Oskarsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Oskarsson more than expected).

Fields of papers citing papers by Per Oskarsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Oskarsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Oskarsson. The network helps show where Per Oskarsson may publish in the future.

Co-authorship network of co-authors of Per Oskarsson

This figure shows the co-authorship network connecting the top 25 collaborators of Per Oskarsson. A scholar is included among the top collaborators of Per Oskarsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Oskarsson. Per Oskarsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Oskarsson, Per, et al.. (2017). Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial. Diabetologia. 61(3). 539–550. 126 indexed citations

Hedman, Christina A., Jan Frystyk, Torbjörn Lindström, Per Oskarsson, & Hans J. Arnqvist. (2013). Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF‐I bioactivity than continuous subcutaneous insulin infusion. Clinical Endocrinology. 81(1). 58–62. 21 indexed citations

Battelino, Tadej, Moshe Phillip, Nataša Bratina, et al.. (2011). Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes. Diabetes Care. 34(4). 795–800. 350 indexed citations breakdown →

Lins, Per‐Eric, et al.. (2010). Basal Insulin Substitution with Glargine or Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Patients—A Randomized Controlled Trial. Diabetes Technology & Therapeutics. 12(9). 689–693. 8 indexed citations

Hedman, Christina A., Jan Frystyk, Torbjörn Lindström, Per Oskarsson, & Hans J. Arnqvist. (2009). Intraperitoneal insulin delivery gives higher circulating IGF-I activity than CSII in type 1 diabetes. 52. 1 indexed citations

Adamson, Ulf, et al.. (2008). Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?. Diabetes & Metabolism. 34(6). 612–616. 119 indexed citations

Odar‐Cederlöf, Ingegerd, Per Oskarsson, Gunnar Öhlén, et al.. (2008). [Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study].. PubMed. 105(12-13). 890–3. 20 indexed citations

Oskarsson, Per, et al.. (2004). [Episodes of severe hypoglycemia--increasing problem in type 1 diabetes].. PubMed. 101(51-52). 4202–5.

Adamson, Ulf, et al.. (2003). A repeated cross‐sectional survey of severe hypoglycaemia in 178 Type 1 diabetes mellitus patients performed in 1984 and 1998. Diabetic Medicine. 20(3). 216–219. 15 indexed citations

10.

Oskarsson, Per, et al.. (2000). Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.. PubMed. 26(2). 118–24. 33 indexed citations

11.

Oskarsson, Per, et al.. (1999). Long-term follow-up of insulin-dependent diabetes mellitus patients with recurrent episodes of severe hypoglycaemia. Diabetes Research and Clinical Practice. 44(3). 165–174. 4 indexed citations

12.

Oskarsson, Per, et al.. (1999). Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion.. PubMed. 25(6). 491–7. 18 indexed citations

13.

Oskarsson, Per, et al.. (1997). Effects of C-peptide on insulin-induced hypoglycaemia and its counterregulatory responses in IDDM patients. Diabetic Medicine. 14(8). 655–659. 5 indexed citations

14.

Oskarsson, Per, Jan‐Gustaf Ljunggren, & Per‐Eric Lins. (1997). Efficacy and Safety of Mexiletine in the Treatment of Painful Diabetic Neuropathy. The Mexiletine Study Group. Diabetes Care. 20(10). 1594–1597. 106 indexed citations

15.

Björk, Erik, Christian Berne, Olle Kämpe, et al.. (1996). Diazoxide Treatment at Onset Preserves Residual Insulin Secretion in Adults with Autoimmune Diabetes. Diabetes. 45(10). 1427–1430. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact